Cargando…
Self-adjuvanting cancer nanovaccines
Nanovaccines, a new generation of vaccines that use nanoparticles as carriers and/or adjuvants, have been widely used in the prevention and treatment of various diseases, including cancer. Nanovaccines have sparked considerable interest in cancer therapy due to a variety of advantages, including imp...
Autores principales: | Liao, Zhiyun, Huang, Jing, Lo, Pui-Chi, Lovell, Jonathan F., Jin, Honglin, Yang, Kunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316869/ https://www.ncbi.nlm.nih.gov/pubmed/35883176 http://dx.doi.org/10.1186/s12951-022-01545-z |
Ejemplares similares
-
Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research
por: Hu, Yan, et al.
Publicado: (2022) -
A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses
por: Chen, Sisi, et al.
Publicado: (2022) -
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines
por: Skwarczynski, Mariusz, et al.
Publicado: (2020) -
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022) -
Bacterial outer membrane vesicle-based cancer nanovaccines
por: Gao, Xiaoyu, et al.
Publicado: (2022)